Mathematical models provide mechanisms to evaluate the potential efficacy of public health interventions. While traditional models of tuberculosis have relied on parameters obtained from historical observation, there is a pressing need to develop models that depend more directly on actual surveillance and contact-tracing data. Additionally, treatment outcomes of patients with drug-resistant tuberculosis are often compromised by the delay before detailed drug resistance profiles are available. In practical terms, this means that patients with drug-resistant disease are often treated with inappropriate or ineffective drugs for many months. We have previously developed an Electronic Medical Record (EMR) to facilitate clinical care of tuberculosis patients;here we propose to extend this platform to function as a research tool.
The specific aims of this project are to: (1) develop a surveillance system for multi-drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis based on the EMR established in Lima, Peru;(2) develop realistic models of tuberculosis transmission that capture important individual and community heterogeneities and use these models to assess the impact of specific control policies; and (3) use surveillance data to develop an individual prediction model for drug resistance profiles that will serve as a decision support tool for choosing appropriate tuberculosis drug regimens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI076217-04
Application #
8136607
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
4
Fiscal Year
2010
Total Cost
$554,560
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Aibana, Omowunmi; Franke, Molly F; Huang, Chuan-Chin et al. (2018) Vitamin E Status Is Inversely Associated with Risk of Incident Tuberculosis Disease among Household Contacts. J Nutr 148:56-62
Rodriguez, Carly A; Smith, Emily R; Villamor, Eduardo et al. (2017) Development and Validation of a Food Frequency Questionnaire to Estimate Intake among Children and Adolescents in Urban Peru. Nutrients 9:
Calderón, R I; Velásquez, G E; Becerra, M C et al. (2017) Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru. Int J Tuberc Lung Dis 21:894-901
Velásquez, Gustavo E; Calderon, Roger I; Mitnick, Carole D et al. (2017) Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrob Agents Chemother 61:
Velásquez, Gustavo E; Calderon, Roger I; Mitnick, Carole D et al. (2016) Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrob Agents Chemother 60:6766-6773
Aibana, Omowunmi; Acharya, Xeno; Huang, Chuan-Chin et al. (2016) Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts. PLoS One 11:e0166333
Martinot, Amanda J; Farrow, Mary; Bai, Lu et al. (2016) Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis. PLoS Pathog 12:e1005351
Lahiri, Nivedita; Shah, Rupal R; Layre, Emilie et al. (2016) Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis. J Biol Chem 291:14248-56
Van Rhijn, Ildiko; Moody, D Branch (2015) CD1 and mycobacterial lipids activate human T cells. Immunol Rev 264:138-53
Rock, Jeremy M; Lang, Ulla F; Chase, Michael R et al. (2015) DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader. Nat Genet 47:677-81

Showing the most recent 10 out of 31 publications